Connect with us

GLOBAL PANDEMIC

Should You Wear a Mask If You Get the COVID Vaccine?

Published

on

Should You Wear a Mask If You Get the COVID Vaccine
Should You Wear a Mask If You Get the COVID Vaccine? With the spread of the delta variant in the United States and the increasing number of states reducing pandemic mask requirements, experts warn that even those who are fully vaccinated against COVID-19 may be at risk.

Should You Wear a Mask If You Get the COVID Vaccine?

Should You Wear a Mask If You Get the COVID Vaccine? Read more about COVID -19 on the World Health Organization‘s Official COVID -19 page. Information about Symptoms, Prevention, Travel Advice, Vaccines and Coronavirus Frequently Asked Questions. Updates. All information in one place. Status updates.

  • Experts are considering whether vaccinated people should continue to wear masks during the pandemic.
  • They say the vaccine does not mean there is no risk of contracting the virus.
  • The spread of new variants, including Delta, may complicate understanding the effectiveness of COVID-19 vaccines.

With the spread of the delta variant in the United States and the increasing number of states reducing pandemic mask requirements, experts warn that even those who are fully vaccinated against COVID-19 may be at risk.

Given the threat posed by Delta and other coronavirus variants, should vaccinated people continue to wear masks? Experts say that vaccination does not mean you are completely protected from developing COVID-19.

“While the chance of contracting COVID-19 after a person is vaccinated is low, it is not zero,” Teresa Murray Amato, head of emergency medicine at Long Island Jewish Forest Hills in New York, told Healthline.

Coronavirus variants pose a risk to everyone

According to the Centers for Disease Control and Prevention (CDC), as of July 7, about 55 percent of Americans have received at least one dose of COVID-19 vaccine, and roughly 47 percent of all Americans are fully vaccinated.

However, new variants may present new risks.

The Times of Israel reported this week that recent research has found that Pfizer’s mRNA vaccine is “less effective” with approximately 60 percent protection against delta. But it was still over 90 percent protective against hospitalization. Another preprint of a study found an mRNA vaccine that was effective against a lambda variant discovered in Peru.

The ongoing evolution of the novel coronavirus with new variants makes a critical decision about whether or not to make masks for vaccinated people.

CDC director: Vaccine provides ‘high degree’ of protection

CDC director Dr. Rochelle Walensky said at a briefing last week that vaccines are still highly effective against variants and that the vast majority of new COVID-19 cases and deaths are in unvaccinated people.

“Our authorized vaccines protect against variants circulating in this country, including delta,” he said at the briefing. “Vaccination is how we protect these individuals, families and communities and prevent serious illness, hospitalizations and deaths from COVID-19.”

Amato recommended that people with a high probability of serious illness consult a healthcare professional about the use of masks.

“If you are vulnerable to a bad outcome with a COVID-19 infection due to an underlying condition, please talk to your doctor about the risks and benefits of wearing a mask,” he said.

He added that masks reduce contamination.

“We know that getting vaccinated and wearing a mask reduces the spread of COVID-19,” Amato said. “The more we can reduce transmission, the more we can reduce the chance of new variants appearing.”

Groups that favor staying masked

The Los Angeles County of Public Health already “strongly recommends” masking for everyone, regardless of vaccination status.

According to a July 1 press release, “With the increasing circulation of the highly contagious delta variant, the Los Angeles County Department of Public Health (Public Health) strongly recommends that everyone, regardless of vaccination status, wear masks indoors in public as a precautionary measure.” eviction from the agency.

The World Health Organization (WHO) has urged itsTrusted Source As the delta variant increases in many parts of the world, people with full vaccinations should continue to wear masks indoors and practice physical and social distancing.

Amato noted that the unpredictability of the pandemic has made it difficult to inform public health policy.

“As we continue to progress through many stages of the COVID pandemic, we continue to experience challenges with mask wearing recommendations,” he said.

Who should still wear a mask?

Current CDC guidanceTrusted Source is that fully vaccinated people can continue their activities without wearing masks or physical distancing.

Global Health Director Dr. “I don’t believe the CDC needs to change its guidance for vaccinated people at this time, as there is very good evidence that vaccinated people are very rarely infected with COVID-19,” said Eric Cioe-Peña. Northwell Health is in New Hyde Park, New York.

He stressed that when vaccinated people get the coronavirus, they “have extremely mild symptoms and are less able to transmit the disease to other people, especially when others are also fully vaccinated.”

But he said unvaccinated people should “absolutely” wear masks until they are vaccinated, as these people are at risk of contracting more serious illnesses due to catching and variants. He added that COVID-19 variants do not pose a significant threat to vaccinated people.

Cioe-Peña stressed that the delta variant and others (such as delta plus) are more contagious and may result in greater disease severity.

“Fortunately, all vaccines approved in the United States showed very good efficacy against delta and all other circulating variants,” he said.

He also warned that “a variant could develop that would circumvent vaccine-induced immunity, as demonstrated by some vaccines not approved for use in the United States but used worldwide.”

Cioe-Peña said the existence of the delta variant should serve as a “very solemn reminder” that the pandemic is not over.

“We must continue to inoculate the world and the rest of the United States,” he said. “We are not ready. There is still a lot of work to be done and we cannot relax just because we are winning.”

Note:

There is debate over whether fully vaccinated people should continue to wear masks and observe physical distancing.

While the WHO recommends that everyone should wear a mask regardless of their vaccination status, the CDC argues that fully vaccinated people do not have to.

Experts insist that currently approved vaccines are highly effective against COVID-19 and its known variants. However, they also say that those with a high chance of experiencing serious illness should consult a healthcare professional before deciding to stop wearing masks.

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

GLOBAL PANDEMIC

Concerns about the Delta Variant are growing.

Published

on

By

Concerns about the Delta Variant are growing.
Why Are People Worried About the Rise of the Delta Variant? Concerns about the Delta Variant are growing. The delta differential is spreading globally.

Why Are People Worried About the Rise of the Delta Variant?

Concerns about the Delta Variant are growing.

  • The delta differential is spreading globally.
  • Experts think that this version is more than previous variants of the virus.
  • Although some vaccinated folk have developed COVID-19 in their delta version, they seem to have less than unvaccinated people today.

Concerns about the Delta Variant are growing. The delta variant of the new coronavirus is spreading rapidly globally and is widely practiced all over the world, where there have been large numbers of COVID-19 cases before. First of all, this version of the English version has more information about “notification” as “now in alpha”.

Stored at Northwell Health in Manhasset, NY, Dr. “This is America, it’s the delta,” said roughly 25 percent of the new filings [in the United government],” said David H. “In the country’s women, the percentage is higher and will be under attack in the US in the coming weeks.”

So what exactly is the delta variant of COVID-19 and what do we need to know about it? To deliver what is designed to shed some light on the subject.

What is the delta variable?

The delta variant is a version of the virus in more than 80 countries since its first detection in India. The delta variant is now potentially responsible for more than 90 percent of all new cases in the UK, according to the take from Public Health England.

In the United States, roughly 25 percent of all new cases are believed to be, but this is increasing so rapidly.

Who is at risk for the delta variant?

In the United States, the delta variant mostly affects unvaccinated or only partially vaccinated people.

According to the Centers for Disease Control and Prevention, about 78 percent of the population over 65 are vaccinated. It is spreading among many seniors and patients in their 20s, 30s and 40s.

“It’s extraordinarily contagious,” said Vanderbilt University in Tennessee. “Given that it is so contagious, remember that the virus’s only job is to infect someone else so it can continue to reproduce.”

Continue Reading

GLOBAL PANDEMIC

COVID Cases Delta Variant and What’s Happening?

Published

on

By

COVID Cases Delta Variant
COVID-19 Cases, Delta Variant and What's Happening Now? The delta variant of the coronavirus SARS-CoV-2 is seen more and more frequently on Earth. The delta variant, first identified in India, is progressing and is expected to replace the alpha variant (originally known as the UK variant) as the dominant species during the summer.

COVID-19 Cases, Delta Variant and What’s Happening Now?

COVID Cases Delta Variant and What’s Happening? The delta variant of the coronavirus SARS-CoV-2 is seen more and more frequently on Earth. The delta variant, first identified in India, is progressing and is expected to replace the alpha variant (originally known as the UK variant) as the dominant species during the summer.

  • Federal officials estimate that the delta variant of the coronavirus is currently the dominant variant in the United States.
  • The alpha variant, which once accounted for more than two-thirds of new COVID-19 cases in the United States, now accounts for less than one-third of cases.
  • The latest CDC estimate shows that the delta variant accounted for 51.7 percent of COVID-19 cases during the 2 weeks ending July 3.

The highly contagious delta variant of the coronavirus currently accounts for the majority of COVID-19 cases in the United States, according to a recent estimate from the Centers for Disease Control and Prevention (CDC).

Since the delta variantTrusted Source was first detected in the United States in March, it quickly outstripped other variants of the virus.

During the 2 weeks ending June 5, it accounted for 10.1 percent of COVID-19 cases, increasing to 30.4 percent of cases by June 19.

The latest CDC estimate shows the delta variant accounting for 51.7 percent of cases for the 2 weeks ending July 3.

The alpha variant, which once accounted for more than two-thirds of new COVID-19 cases in the United States, now accounts for less than one-third of cases.

The rapid spread of the delta variant, also known as B.1.617.2, is not unexpected.

In the United Kingdom, which has a similar full vaccination rate as the United States, the delta variant quickly replaced the alpha variant. A government survey showed that by mid-June it accounted for about 90 percent of infections.

CDC Director Dr. “Although we expect the delta variant to be the dominant strain in the United States, this rapid rise is disturbing,” Rochelle Walensky said at the COVID-19 briefing at the White House on July 8.

“We know that the delta variant is increasing contagiousness and is currently increasing in the country’s pockets with low vaccination rates,” he said.

CDC data show that in parts of the Midwest and Upper Mountain States, the delta variant accounts for about 75 to 80 percent of cases.

Even as the delta variant gains ground, overall COVID-19 cases, hospitalizations and deaths in the United States are much lower than peaks seen earlier in the pandemic.

But “We’re starting to see some new and relevant trends,” said Walensky. “Simply put, cases and hospitalizations have increased in areas with low  vaccine coverage.”

These increases are seen in several states, including Nevada, Iowa, Arkansas, Alaska and Mississippi, according to data tracked by The New York Times.

Missouri is currently a leading COVID-19 hotspot. The rise in COVID-19 cases in the south of the state has forced some hospitals to transfer patients to other facilities, according to local news.

Clusters of COVID-19 outbreaks related to the delta variant have also occurred in low-vaccination zones, summer camps, and recreational facilitiesTrusted Source.

COVID-19 vaccines still effective against delta.

D., an infectious disease physician at The Ohio State University Wexner Medical Center. Ashley Lipps emphasized that vaccination is the best protection against the delta variant.

COVID-19 vaccines appear to provide high efficacy against the delta variant,” he said, “so the risk is much lower for those who are fully vaccinated compared to those who are not.”

Although some studies report that the delta variant may be more likely to cause breakthrough infections in fully vaccinated people, vaccines still protect against serious illness, hospitalization and death.

But more recent research shows that with two-dose vaccines such as the Pfizer-BioNTech vaccine and the Moderna vaccine, taking the second dose is crucial for full protection.

According to the CDC, only 47.8 percent of the total U.S. population is fully vaccinated. Rates are even lower in many states in the South and some in the West.

This has created two nations: one emerging from the pandemic and the other still at serious risk of COVID-19.

While older adults and people with existing health conditions such as diabetes, heart disease and obesity are at risk of serious illness from COVID-19, people under 40 can still go to the hospital.

The rapid but uneven release of COVID-19 vaccines in the US has made one thing clear: Severe COVID-19 is now largely a disease in unvaccinated people.

“Preliminary data from several states over the past few months shows that 99.5 percent of deaths from COVID-19 in the United States are unvaccinated people,” Walensky said at a White House briefing. “These deaths could have been avoided with one safe shot.”

Brandon Brown, an associate professor at the University of California, Riverside School of Medicine, said the delta variant‘s ability to spread more easily has implications for everyone, regardless of their vaccine status.

“Infections and hospitalizations may continue to rise,” he said, “and it is possible for fully vaccinated people to transmit the virus to others who are not vaccinated.”

Fully vaccinated people are much less likely to get an infection, greatly reducing their ability to transmit the virus.

But scientists are trying to determine exactly how often fully vaccinated people who get the infection transmit the virus to others.

Additionally, large numbers of COVID-19 cases in an area can disrupt health systems, leading to delays in screenings and medical treatments for all people in that area.

Masks provide additional protection against delta.

Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases, reiterated at the July 8 White House briefing that the CDC’s mask recommendation has not changed, despite the rapid spread of the delta variant.

“If you’ve been vaccinated, you have a very high degree of protection and so you don’t need to wear a mask,” he said.

But some health officials say the masks add an additional level of protection against this highly contagious strain.

“With so many unknowns, it makes sense to wear face masks when indoors in public or outside in crowded areas,” Brown said, and continues to do so.

However, “everyone has their own personal preferences for increased physical distancing and social interaction,” he said, “which can go beyond local regulations.”

COVID-19 vaccines are not yet approved for children under the age of 12 in the United States.

On July 9, the CDC updated its guide for K-12 schools, emphasizing the vaccination of as many older children as possible before the fall.

Masks, physical distancing, increased ventilation and other measures will be required to reduce the risk of coronavirus transmission in schools for young children.

Lipps said it is important to remember that while COVID-19 vaccines, like all vaccines, are highly effective, they do not provide full protection.

“It’s important to consider additional precautions that may pose a higher risk in certain situations. For example, when gathering indoors with large groups of people, especially if you have underlying health conditions,” he said.

Such situations are more risky in areas of the country with high case numbers and low vaccination rates.

For unvaccinated or partially vaccinated people, masking, physical distancing and other measures remain the main ways to protect themselves from coronavirus, including the delta variant.

But vaccination can provide even more protection.

“People who are not vaccinated are at greatest risk for infection and disease,” Lipps said. “If you haven’t been vaccinated yet, you still have time to do so.”

 

Continue Reading

GLOBAL PANDEMIC

COVID-19 vaccines and their effects in new variants.

Published

on

By

COVID-19 vaccines and their effects in new variants.
Will the COVID-19 vaccines offer protection against the new strains? You may be wondering if the coronavirus variants have an impact on the effectiveness of our current vaccines.

Will the COVID-19 vaccines offer protection against the new strains?

COVID-19 vaccines and their effects in new variants. You may be wondering if the coronavirus variants have an impact on the effectiveness of our current vaccines.

From what we know so far, it appears that the current vaccines may be less effective for B.1.351, the variant first identified in South Africa. This is currently an area of ongoing, intense research.

Let’s look at a snapshot of what some of the data says so far.

Pfizer-BioNTech vaccine

Large-scale clinical trials of the Pfizer-BioNTech vaccine found a vaccine effectiveness of 95 percent against the original version of the new coronavirus.

This vaccine is currently authorized for emergency use in the United States.

A recent study investigated the effectiveness of this vaccine for test viruses containing the mutations found in B.1.351. To do this, serum from individuals who had been vaccinated with the Pfizer-BioNTech vaccine was used.

Researchers found that this serum, which contains antibodies, was less effective against B.1.351. In fact, neutralization of test viruses containing all of the mutations present in B.1.351 was reduced by two-thirds.

What about B.1.1.7, the variant first seen in the U.K.?

A study similar to the one we’ve discussed above found that neutralization of test viruses with the spike protein of B.1.1.7 was only slightly lower than it was for earlier versions of the coronavirus.

Moderna vaccine

The large-scale clinical trials on the Moderna vaccine determined that vaccine effectiveness was 94.1 percent against the original version of the new coronavirus.

Like the Pfizer-BioNTech vaccine, the Moderna vaccine has been authorized for emergency use in the United States.

A recent study looked into the effectiveness of the Moderna vaccine for the B.1.1.7 and B.1.351 variants. In order to do this, researchers used serum from individuals who had received the Moderna vaccine and test viruses containing the spike proteins from the variants.

It was found that test viruses with the B.1.1.7 spike protein were neutralized in a similar manner to earlier versions of the coronavirus.

However, neutralization of test viruses with the spike protein of B.1.351 was 6.4-fold lower.

Johnson & Johnson vaccine

The Johnson & Johnson vaccine is the third COVID-19 vaccine to be authorized for emergency use in the United States.

Unlike the Pfizer-BioNTech and Moderna vaccines, it only requires one dose.

This vaccine has yet to be tested against specific variants. However, large-scale clinical trials were performed in places where variants are circulating, such as South Africa and South America.

According to the data released from clinical trialsTrusted Source, the effectiveness of this vaccine 28 days after vaccination is:

  • 66 percent effective overall
  • 72 percent in the United States
  • 66 percent effective in South America, where the P.1 variant is circulating
  • 57 percent effective in South Africa, where the B.1.351 variant is circulating
  • 85 percent effective at preventing severe COVID-19 symptoms across all geographical regions

Other COVID-19 vaccines

What about some of the other COVID-19 vaccines around the world? How effective are they against the new coronavirus variants?

A recent publication from the British Medical Journal (BMJ)Trusted Source summarizes what we know so far about different COVID-19 vaccines and the more widespread variants.

Here’s what’s known so far about their effectiveness:

  • Oxford/AstraZeneca. The Oxford/AstraZeneca vaccine has an 82.4 percent effectiveness overall. It’s been found to be 74.6 effective against B.1.1.7. However, it may only be 10 percent effective against B.1.351.
  • Novavax. The Novavax vaccine is 95.6 percent effective overall. It’s 85.6 percent effective against B.1.1.7 and 60 percent effective against B.1.351.
  • Sinopharm. This vaccine, produced in China, has an effectiveness of 79.34 percent. However, early reports indicate that it’s less effective against B.1.351.

The race between the vaccine and coronavirus mutations

As long as the new coronavirus continues to circulate, we’ll continue to see new variants emerge.

However, there’s one vital tool we can use to help slow the transmission of the coronavirus as well as the emergence of variants. That tool is vaccination.

The FDA has authorized three COVID-19 vaccines for emergency use in the United States. All three of these vaccines have been found to be safe and effective in large-scale clinical trials.

Even if the current vaccines are less effective against some variants, they still provide some level of protection from becoming sick with COVID-19. Additionally, when more people have some immunity, the transmission of the virus can be slowed.

That’s why it’s so important to get vaccinated when it’s your turn. If you have questions or concerns regarding COVID-19 vaccination, be sure to discuss them with your doctor.

Protecting yourself from coronavirus variants

In addition to vaccination, it’s important to continue to carefully practice preventive measures in order to protect yourself from the coronavirus and its variants. These measures include:

  • Mask wearing. Wear a mask that covers your nose and mouth when you’re out in public or near others outside of your household. Make sure your mask has at least two to three layers of fabric.
  • Try double masking. Speaking of layers, consider double masking. ResearchTrusted Source from the CDC has shown double masking is very effective at preventing exposure to respiratory droplets that may contain virus.
  • Wash your hands. Wash your hands with soap and water. Use hand sanitizer with at least 60 percent alcohol if this isn’t available. Clean hands are particularly important after being in public and before touching your nose, mouth, or eyes.
  • Practice physical distancing. Try to stay at least 6 feet away from people outside of your household. Additionally, aim to avoid areas that are crowded or have poor ventilation.
Continue Reading

Trending